Cancer incidence attributable to the use of oral contraceptives and hormone therapy in Alberta in 2012.

ABSTRACT:

Background

Hormonal contraceptives and hormone replacement therapies are classified as carcinogenic to humans (group 1) by the International Agency for Research on Cancer. We sought to estimate the proportion and total number of cancers attributable to the use of oral contraceptives and hormone therapy in Alberta in 2012.

Methods

Population attributable risks were used to estimate the proportion of attributable cases for each associated cancer site. Relative risk estimates were obtained from the most relevant and recent epidemiologic literature. Prevalences of the use of oral contraceptives and hormone therapy in Alberta were collected from Alberta's Tomorrow Project. Specific cancer incidence data were obtained from the Alberta Cancer Registry for the year 2012.

Results<

SUBMITTER: Grevers X 

PROVIDER: S-EPMC5173458 | biostudies-literature | 2016 Oct-Dec

REPOSITORIES: biostudies-literature